Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Other Non-Current Liabilities (2016 - 2025)

Healthstream (HSTM) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 277.49% to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, up 277.49% year-over-year, with the annual reading at $7.9 million for FY2025, 277.49% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $7.9 million at Healthstream, up from $2.0 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $7.9 million in Q4 2025, with the low at $1.5 million in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $2.4 million, with a median of $2.2 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities soared 521.29% in 2021, then tumbled 59.98% in 2022.
  • Over 5 years, Other Non-Current Liabilities stood at $1.5 million in 2021, then skyrocketed by 49.63% to $2.2 million in 2022, then rose by 3.21% to $2.3 million in 2023, then decreased by 7.89% to $2.1 million in 2024, then surged by 277.49% to $7.9 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $7.9 million, $2.0 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.